Colorectal Cancer Clinical Trials in Raleigh, NC

Colorectal Cancer Clinical Trials in Raleigh, NC

View the best 10 colorectal cancer medical studies in Raleigh, North Carolina. Access promising new therapies by applying to a Raleigh-based Colorectal Cancer clinical trial.

Top rated colorectal cancer clinical trials in Raleigh, North Carolina

Here are the top 10 medical studies for colorectal cancer in Raleigh, North Carolina

Image of NRG Oncology - Pittsburgh Center in Pittsburgh, United States.

Capecitabine +4 More

Chemotherapy

Recruiting1 awardPhase 2 & 3
This trial tests how well ctDNA testing in the blood predicts treatment for patients with stage IIA colon cancer after surgery. ctDNA are circulating tumor cells that are shed by tumors into the blood. Finding ctDNA in the blood means that there is very likely some small amounts of cancer that remain after surgery. However, this cancer, if detected, cannot be found on other tests usually used to find cancer, as it is too small. Testing for ctDNA levels may help identify patients with colon cancer after surgery who do benefit, and those who do not benefit, from receiving chemotherapy.
Image of Mayo Clinic in Arizona in Scottsdale, United States.

Panitumumab +2 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial is comparing panitumumab to the standard of care for treating patients with colorectal cancer that has spread and is negative for RAS wild-type.
Image of Duke Cancer Institute in Durham, United States.

mHealth Coping Skills Training for Symptom Management (mCOPE)

Behavioral Intervention

Recruiting1 award4 criteria
This trial is testing whether an app can help young and middle-aged colorectal cancer patients with pain, fatigue, and distress. The app would teach patients coping skills and provide personalized real-time feedback.
Image of Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill in Chapel Hill, United States.

Palbociclib +1 More

CDK4/6 Inhibitor

Recruiting1 awardPhase 2
This trial will study the effects of cetuximab and palbociclib when used together to treat patients with metastatic colon cancer.
Image of Mayo Clinic Arizona in Phoenix, United States.

Inavolisib +7 More

PI3K Inhibitor

Recruiting1 awardPhase 1
This trial is testing targeted therapies and immunotherapy as single agents or combinations for people with mCRC whose tumors are positive for certain biomarkers.
Image of CTCA at Western Regional Medical Center in Goodyear, United States.

Trastuzumab +3 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial studies trastuzumab and pertuzumab compared to cetuximab and irinotecan hydrochloride in treating patients with HER2/neu amplified colorectal cancer.
Image of SWOG in Portland, United States.

Cetuximab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 2
This trial is testing whether adding nivolumab to the usual treatment of encorafenib and cetuximab works better at shrinking tumors in patients with colorectal cancer that has spread or cannot be removed by surgery.
Image of City of Hope National Medical Center in Duarte, United States.

Sotorasib +1 More

Small Molecule Drug

Recruiting2 awardsPhase 3
This trial is testing two doses of a new drug, sotorasib, to see if it can help people with a certain type of colorectal cancer that has come back after treatment.
Image of Virginia Commonwealth University Massey Cancer Center in Richmond, United States.

mFOLFOX +1 More

Anti-metabolites

Recruiting1 awardPhase 2
This trial is testing a new way to treat rectal cancer that may be less intense and have fewer side effects.
Image of Yale University Cancer Center in New Haven, United States.

GEN1042

Monoclonal Antibodies

Recruiting1 awardPhase 1 & 2
This trial will test how safe and effective GEN1042 is in treating patients with metastatic or locally advanced solid tumors.

Popular filter options for colorectal-cancer raleigh trials

Phase 3 Clinical Trials

View 59 phase 3 medical studies.

Clinical Trials With No Placebo

View 59 medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.